Cancer Therapy
Photodynamic therapy with mTHPBC is safe and feasible treatment for liver metastases
Published in Medical Devices and Surgical Technology Week, November 27th, 2005
"The prognosis for patients with liver metastases from colorectal carcinoma is limited because of the low number of patients who are eligible for curative hepatic resection. In this phase I study, 31 liver metastases in 24 patients with nonresectable metastases from colorectal carcinoma were treated with photodynamic therapy (PDT). The photosensitizer 5,10,15,20-tetrakis(m-hydroxyphenyl)bacteriochlorin (mTHPBC) was intravenously administered in a dose of 0.6 mg/kg (n=12) or 0.3 mg/kg (n=12),"...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- Coronary Artery Bypass
Triple-site triggered atrial pacing reduces risk of post-CABG atrial fibrillation - Dental Research
Novel intraoral lubricating device improves xerostomia management - Heart Failure
CorCap cardiac support device improves surgical outcome in patients with cardiomyopathy - Medical Devices
Novel photoplethysmographic probe provides automatic ankle pressure assessment - Medical Devices
ThromboCheck enables home monitoring of prosthetic valves via digital frequency analysis - Adverse Drug Reaction
Patients develop acute liver failure after receiving amoxicillin/clavulanate - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
